Alexandria Venture Investments

Alexandria Venture Investments

Alexandria Venture Investments

Follow us
GeekWire

Silverback Therapeutics to merge with San Diego biotech company developing EpiPen alternative

Pulse 2.0

Homology Medicines (FIXX) Stock Price: Why It Increased Over 2% Today

Pulse 2.0

Codiak BioSciences (CDAK) Stock: Why The Price Grew 10.14% Today

AlleyWatch

TARA Biosystems Acquired by Valo Health

GeekWire

Silverback Therapeutics shuts down oncology program, plans to lay off 27% of workforce

MedCity News

Celsius Therapeutics heats up with $83M and an IBD drug on path to the clinic

Pulse 2.0

Homology Medicines (FIXX) Stock: Why Its Trending Today

Pulse 2.0

TCR2 Therapeutics Stock (TCRR): $5 Price Target From Goldman Sachs

Pulse 2.0

Metacrine Stock (MTCR): Why The Price Fell Today

Pulse 2.0

Codiak BioSciences (CDAK) Stock: Why The Price Jumped Today

Pulse 2.0

Jasper Therapeutics (JSPR) Stock: Why The Price Increased Today

$120,000,000 Venture capital
AFN

Shenandoah Growers rebrands as Soli Organic with $120m to build more soil-based indoor farms

$215,000,000 Venture capital (Series B)
TechCrunch

Immunai announces a $215M Series B as its ‘immune cell atlas’ matures

$90,000,000 Venture capital (Series B)
MedCity News

Blood disorder biotech Disc Medicine gets $90M to bring two drugs into Phase 2

$108,000,000 Venture capital (Series B)
MedCity News

Asher Bio’s encouraging early data against rival cancer drug sparks $108M financing

$5,000,000 Venture capital
SiliconRepublic

Biotech co-founded by UCC graduates raises $5m funding

€75,000,000 Venture capital (Series A)
Sifted

Round size surge gives France largest-ever Series A

$50,000,000 Venture capital (Series B)
GeekWire

Seattle startup TwinStrand raises $50M to expand tech that identifies rare genetic mutants

GeekWire

Seattle biotech OncoResponse raises $40.6M to create antibody-based treatments for cancer

neurons.AI

insitro raises $400M for machine learning-powered drug discovery efforts